Fujifilm opens new iPSC manufacturing facility in Madison in $200 million investment

  • Fujifilm Holdings Corporation opened a new 175,000-square-foot headquarters and iPSC development and manufacturing facility for its Cellular Dynamics unit in Madison, Wisconsin.
  • The site is expected to quadruple iPSC-based research products and services manufacturing capacity, supporting expanded output of iPSC-derived iCell lines used in drug discovery.
  • The facility forms part of a previously announced USD 200 million strategic investment, with scalable infrastructure intended to support both investigational and commercial cell therapy manufacturing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fujifilm Holdings Corporation published the original content used to generate this news brief on May 20, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.